In Depth 14 Apr 2025
Metabolomics: The study of biology’s dark matter
Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research.
In Depth
- Latest Posts
In Depth 11 Apr 2025
Basel: What’s behind the success of one of Europe’s leading biotech hubs?
Find out what makes Basel’s biotech hub so successful, as it has cemented its place as one of Europe’s brightest life sciences ecosystems.
In Depth 9 Apr 2025
Cystic fibrosis: is the next blockbuster a gene therapy?
Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.
In Depth 7 Apr 2025
Will tRNA therapy be the next big thing in genetic disease treatment?
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
In Depth 1 Apr 2025
The biggest biotech funding rounds in March 2025
The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.
ADVERTISEMENT
ADVERTISEMENT
In Depth 26 Mar 2025
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
In Depth 19 Mar 2025
Breast cancer treatments heat up: Five therapies poised to transform patient outcomes
Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.
In Depth 17 Mar 2025
How biotechs are using AI to rescue failed drugs
Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.
In Depth 14 Mar 2025
Can GLP-1 agonists help treat addiction?
Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
ADVERTISEMENT
